| Albert C Reynaud, MD | |
|
801 N 29th St, Billings, MT 59101-0905 | |
| (406) 238-2500 | |
| Not Available |
| Full Name | Albert C Reynaud |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Location | 801 N 29th St, Billings, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104924000 | NPI | - | NPPES |
| 102349700 | Other | WY | MDCD PIN |
| 0011254 | Other | MT | MDCD PIN |
| 312698 | Other | WY | BCBS PIN |
| 000093970 | Other | MT | BCBS PIN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 6051 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Albert C Reynaud, MD Po Box 35100, Billings, MT 59107-5100 Ph: (406) 238-2500 | Albert C Reynaud, MD 801 N 29th St, Billings, MT 59101-0905 Ph: (406) 238-2500 |
News Archive
In a post in the Global Health Technologies Coalition's "Breakthroughs" blog, GHTC's Kim Lufkin reports on her travels to Kenya this month "to visit global health research projects and see the impact on people in the country," writing, "Although we visited a range of projects, I was left with the lasting impression that much of this research is so close to producing new health tools that can lead to amazing innovations in public health," including "the first ever malaria vaccine, gels women can use to protect themselves from HIV, and new drugs for neglected diseases that affect the poorest of the poor."
Asthmatic patients may soon have a more effective way to control the condition, thanks to a new pharmacological discovery by researchers from the National University of Singapore (NUS).
The team of Bruno Giros, a researcher at the Douglas Mental Health University Institute and professor of psychiatry at McGill University, reports the first-ever connection between noradrenergic neurons and vulnerability to depression. Published in the journal Nature Neuroscience, this breakthrough paves the way for new depression treatments that target the adrenergic system.
A revolutionary clinical study has demonstrated the effectiveness of a new drug, vismodegib, in dramatically shrinking and preventing the formation of basal cell skin cancers - the most common cancer in the United States - in patients with basal cell nevus syndrome (BCNS), a rare genetic condition that causes hundreds to thousands of skin cancers primarily treated by surgical removal.
› Verified 7 days ago
Chloe Nicole Ekelem, MD Dermatology Medicare: Medicare Enrolled Practice Location: 2800 10th Ave N, Billings, MT 59101 Phone: 406-238-2500 | |
Kimberly Kay Blain, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2800 10th Ave N, Billings, MT 59101 Phone: 406-238-2500 | |
Dr. Eric L. Maranda, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 178 S 32nd St W Ste 3, Billings, MT 59102 Phone: 406-702-1323 | |
Brooke Elizabeth Yates, MS PAC Dermatology Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
James Abbott, MD Dermatology Medicare: Medicare Enrolled Practice Location: 2825 8th Ave N, Billings, MT 59101 Phone: 406-238-2500 | |
Diana Norton, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 |